Skip to main content

Find Clinical Trials

Home
Conditions
Adnexal Diseases

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,553 public trials 690 recruiting studies

Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Completed

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

NCT00005104

Conditions: Adnexal Diseases, Cysts, Disease Attributes, +18 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Louisiana State University School of Medicine Shreveport, Louisiana, United States

Washington University - St. Louis St Louis, Missouri, United States

University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

NCT00005654

Conditions: Adnexal Diseases, Cysts, Disease Attributes, +18 more
Locations: Not specified

View Trial Details

Completed

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome

NCT00004311

Conditions: Acanthosis Nigricans, Adnexal Diseases, Cysts, +20 more
Locations: Not specified

View Trial Details

Terminated

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

NCT06206746

Conditions: Adnexal Diseases, Cysts, Endocrine System Diseases, +12 more
Locations: HRC Fertility - Encino Encino, California, United States

UCSF Center for Reproductive Health San Francisco, California, United States

University of South Florida Tampa, Florida, United States

The IVF Center Winter Park, Florida, United States

View all 19 locations

View Trial Details

Terminated

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

NCT04315233

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +18 more
Locations: Huntsman Cancer Institute Salt Lake City, Utah, United States

Inova Schar Cancer Institute Fairfax, Virginia, United States

View Trial Details

Terminated

Engineered Immune Effectors Against Ovarian Cancer

NCT03362606

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Terminated

Genetically Modified T Cells Against Ovarian Cancer

NCT03184753

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Terminated

A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer

NCT06315491

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: TMC Health Tucson, Arizona, United States

View Trial Details

Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions: Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations: Arizona Oncology Associates Tucson, Arizona, United States

Rocky Mountain Cancer Centers Aurora, Colorado, United States

St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States

Ochsner Cancer Institute New Orleans, Louisiana, United States

View all 17 locations

View Trial Details

Terminated

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

NCT05226507

Conditions: ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
Locations: Honor Health Phoenix, Arizona, United States

UC San Diego Health - Moores Cancer Center La Jolla, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Yale Gynecologic Oncology New Haven, Connecticut, United States

View all 22 locations

View Trial Details